Lataa...
Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?
Uzbekistan has a large burden of drug-resistant tuberculosis (TB). To deal with this public health threat, the National TB Program introduced rapid molecular diagnostic tests such as Xpert MTB/RIF (Xpert) and line probe assays (LPAs) for first-line and second-line drugs. We documented the scale-up o...
Tallennettuna:
| Julkaisussa: | Int J Environ Res Public Health |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8124440/ https://ncbi.nlm.nih.gov/pubmed/33924862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph18094685 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|